Company / Current Assets per Share
United Therapeutics Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$82.59
FY2025
5-year range
$52.21 / $82.59
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#6 of 210
Health Care
What the data says
Among 210 Health Care companies, United Therapeutics is in the top 3% for current assets per share. Current Assets per Share has increased for 9 consecutive years, from $31.14 in FY2016 to $82.59 in FY2025.
Based on SEC 10-K filings.
82.59 in FY2025 with a 5-year CAGR of +10.8%. Top quartile in the Health Care sector.
Improved from $77.14 to $82.59 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.3%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
-51.6% below sector average
Key checks
Key Insights
- United Therapeutics's current assets per share has grown for 9 consecutive years.
- In FY2025, current assets per share increased 0.3% year-over-year.
- Ranks #6 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.59 | +0.3% |
| FY2024 | $82.35 | +6.8% |
| FY2023 | $77.14 | +2.9% |
| FY2022 | $74.94 | +43.5% |
| FY2021 | $52.21 | +5.7% |
| FY2020 | $49.38 | +15.5% |
| FY2019 | $42.78 | +4.6% |
| FY2018 | $40.89 | +21.3% |
| FY2017 | $33.70 | +8.2% |
| FY2016 | $31.14 | +15.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026